Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of the International AIDS Society|November 14, 2014
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppressionDominique Costagliola, Jean-Marc Lacombe, Jade Ghosn, et al.
AIDS (London, England)|April 5, 2024
Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohortAmanda Blot-Cossard, Yanis Merad, Antoine Bachelard, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2021
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life settingColin Deschanvres, Jacques Reynes, Isabelle Lamaury, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2022
Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV CentreRomain Palich, Rachid Agher, Dimoke J Wetshikoy, et al.
AIDS (London, England)|July 16, 2019
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trialsChristine Durier, Corinne Desaint, Jean-Daniel Lelièvre, et al.
AIDS (London, England)|October 6, 2018
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy eraHélène Roul, Murielle Mary-Krause, Jade Ghosn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018Laurent Cotte, Laurent Hocqueloux, Maeva Lefebvre, et al.
AIDS (London, England)|July 14, 2010
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trialDominique Salmon-Céron, Christine Durier, Corinne Desaint, et al.
Pageof 9